PTC Therapeutics
PTCT
#2687
Rank
โ‚น557.22 B
Marketcap
โ‚น6,940
Share price
-0.76%
Change (1 day)
69.33%
Change (1 year)

PTC Therapeutics (PTCT) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น251.49 Billion

According to PTC Therapeutics 's latest financial reports the company's total liabilities are โ‚น251.49 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

PTC Therapeutics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น240.46 B6.42%
2023-12-31โ‚น225.95 B33.03%
2022-12-31โ‚น169.86 B17.84%
2021-12-31โ‚น144.14 B14.17%
2020-12-31โ‚น126.25 B71.98%
2019-12-31โ‚น73.41 B36.62%
2018-12-31โ‚น53.73 B257.79%
2017-12-31โ‚น15.01 B47.57%
2016-12-31โ‚น10.17 B9.95%
2015-12-31โ‚น9.25 B320.24%
2014-12-31โ‚น2.20 B132.09%
2013-12-31โ‚น0.94 B-46.28%
2012-12-31โ‚น1.76 B-88.19%
2011-12-31โ‚น14.95 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Vertex Pharmaceuticals
VRTX
โ‚น677.68 B 169.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น195.24 B-22.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
โ‚น9.84 B-96.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
โ‚น22.27 B-91.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚น21.87 B-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.618 T 2,133.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland